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CHAPTER I 
 
INTRODUCTION 
 
Overview of Wound Healing 
Wound healing is a coordinated succession of concurrent biochemical and cellular events 
that result in the restoration of tissue architecture and function [1]. Within the context of normal 
physiology, these processes follow a specific and well-characterized time course. Aging and 
chronic disorders, including diabetes, create pathologies that impair the normal sequence of 
wound healing [2] causing many patients to eventually develop chronic foot ulcers [4-6]. 
Complex wound conditions including thermal and chemical burns result in structures that 
naturally impede the mechanisms of normal wound healing, retarding the time course and 
increasing risk of infection. Wound healing disorders represent a significant health care issue in 
both cost and morbidity, affecting patient quality of life through decreased functional integrity of 
the skin as an organ and frequent limb amputations. An annual cost to the US Health Services in 
excess of $9 billion for age-related wound impairment, underscores the drastic adverse impact of 
impaired wound healing on quality of life through decreased mobility, decreased independence, 
and suffering under chronic pain [7].  
While modern pathology and molecular biology methods have excelled at determining 
normal wound healing mechanisms, application of this knowledge to impaired wound healing 
states have yielded mixed results. Unacceptable mortality rates and a growing number of limb 
amputations, roughly 100,000 per year in the US alone from diabetic foot ulcers, have sparked 
investigation into a variety of novel preventative and treatment strategies for enhancement of 
wound healing.  There is a specific need for a non-invasive technology capable of enhancing 
impaired wound healing through intrinsic mechanisms. The plethora of nascent therapeutic 
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modalities attempting to meet this demand has also given rise to a specific need for detection of 
structural and functional changes within the healing wound to better understand the mechanisms 
of impairment and evaluate treatment response. Ideally, such a technology would readily allow 
for translation of results from laboratory studies to clinical use. 
 
Normal Wound Healing 
To fully understand the complex and balanced process of dermal wound healing, it is best 
framed in the context of the precise composition and overall function of the skin. Paul Martin 
conducts an excellent review of the biological processes involved in dermal wound healing, as a 
function of skin physiology, disease states, and efforts towards "perfect regeneration". Skin is 
composed of a "keratinized stratified epidermis" above a connective tissue matrix, composed 
largely of collagen fibers. The primary function of skin is to serve as a protective barrier against 
the outside world. When this barrier is violated by the creation of a wound, a clot is formed to 
prevent infection and blood loss. The remainder of the wound healing process is an attempt by 
the body to then replace this clot with new skin while still preserving skin function. In a complex 
organizational scheme, each cellular and structural component plays multiple roles to ward 
infection and reestablish structure, starting with the clot. Clots are composed primarily activated 
platelets that cause the cross-linking of fibrin, together forming the structure of the clot. During 
clot formation, the degranulation process of these platelets releases a massive biological signal 
composed of growth factors and cytokines. This triggers all four of the major components of 
early wound repair: the recruitment of inflammatory cells, reepithelialization, wound contraction, 
and wound angiogenesis. [3] 
Though considered the first major step in wound healing, the recruitment of 
inflammatory cells is crucial to the continued process of wound healing. It happens along a well-
characterized time course, and its malfunction is often considered the source of healing 
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impairment in disease states. While platelets do send an essential signal to circulating leukocytes 
involved in the inflammation response, it has been shown that peptides from digested bacteria 
and byproducts of matrix proteolysis also generate important chemotactic gradients that attract 
these crucial cells. Before these immune cells can participate in the wound healing process, they 
first must exit the circulation through the processes of diapedesis and extravasation. Through 
cellular signaling via integrins and selectins, these leukocytes roll along vessel walls, adhere to 
specific sites, and then force their way through the vascular epithelium. This process is of special 
interest because its malfunction is newly attributed to numerous chronic disease states, including 
impaired diabetic wound healing [8, 9].  
Martin explains that within the time course of inflammation, the neutrophils arrive first to 
combat the pathogens due to the wound. Barring serious infection, these neutrophils eventually 
degrade, but not before releasing cytokines to signal to other leukocyte types. After a few days, 
macrophages predominate the wound environment. Macrophages are primarily phagocytic in 
function, digesting foreign bodies, spent neutrophils, cellular debris and matrix byproducts; 
however, macrophages release growth factors that effectively amplify the original signal 
generated by the clot. [3] 
 Reepithelialization is defined as the cumulative actions by which remaining epithelial 
cells (specifically keratinocytes) reform the outermost layers of the skin. This process lags behind 
inflammation for several reasons. In normal skin, the lowest layer of epithelials, the basal 
keratinocytes, are anchored by hemidesmosomes to the special layer of matrix called the basal 
lamina. Before these cells can reform continuous layer destroyed by the wound, they must first 
digest the current hemidesmosomes, alter their expression of integrins, and arrange actin fibers 
for locomotion. This process also has a level of elegance and complexity that is still being 
investigated. Martins reports that more recent studies imply the activity of suprabasal (above the 
basal cells) keratinocytes in locomotion and reestablishing the epithelial layer. Moreover, it has 
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been found that intact cells from remnants of gland or follicle structures also undergo cellular 
changes and act as a locomotive healing front. Beyond locomotion, differentiation, and mitosis, 
these cellular layers must also cut a path through the fibrin clot by expression of matrix 
metalloproteinases (MMPs) and via activation of local plasminogen (within the clot) to yield 
plasmin, one of the few enzymes capable of degrading fibrin. Once the keratinocyte layer is fully 
established, the cells cease to migrate, begin to express "normal" integrins, and reattach to the 
basal lamina. Ongoing research focuses on the regulation of this cellular migration, as the 
expression of growth factors and their relative effects on the involved cells are seen as potential 
targets to modulate wound healing (discussed below). [3] 
Concurrent with, but lagging even further behind reepithelialization is the overall 
contraction of the wound site. Initial contraction is a physical response, as cellular contractile 
fibers assist in bringing the apposed edges of the wound closer together. The majority of the 
contraction process, however, occurs through the degradation and deposition of matrix proteins 
via dermal fibroblasts which proliferate in response to the early cytokine and growth factor 
signals. A 3 to 4 day lag time for this process is reported by Martin, explained by the generation 
of cellular machinery not normally present in the dermal fibroblast, rather than the time required 
for proliferation. Dermal fibroblasts respond not only to local growth factors and cytokine 
signals, but also to the proteins they contact. Ultimately, they are responsible for the digestion of 
the fibrin clot and deposition of the replacement matrix. [3, 8] 
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Beyond the cellular and subcellular orchestration of wound healing signals, the tissue 
level remodeling of the healing wound also appears to be well-regulated. Growth factors 
associated with angiogenesis, specifically VEGF (Vascular Endothelial Growth Factor) and FGF 
(Fibroblast Growth Factor), are expressed by locomotive epithelial fronts to direct the growth of 
new blood vessels. Moreover, Martin cites studies that indicate the regeneration of hair follicles 
and sweat glands that are integral to greater function and maintenance of the skin as an organ. 
Compared to the mechanism of basic wound repair, relatively little is known about the 
 
Figure 1. Cartoon illustrates inflammatory cell infiltration, the moving reepithelialization front, 
and the fibrin clot capillary plexus, characteristic of early wound healing. (P. Martin 1997) [3] 
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mechanisms behind these processes. Nevertheless, studies indicate that the regeneration of these 
structures has been linked to different growth factor expression that corresponds to the end of the 
wound healing time course. These growth factors, in particular, are associated with embryonic 
wound healing, which is noted for its specific lack of scarring. Beyond cosmetic issues, the lack 
of scarring is significant because scars do not contain the level of organization or hierarchical 
structure associated with normal skin. Martin concludes the review with the idea that knowing the 
differences between the two healing processes would provide invaluable knowledge into the 
modulation of intrinsic mechanisms within this highly orchestrated process to achieve better 
results in normal and diseased wound healing.[3]  
To fully achieve a normal reconstruction of skin, the complex structure of the 
extracellular matrix (ECM) must be properly restored. The extracellular matrix consists of both 
fibrillar proteins and glycosaminoglycans, lending it tensile strength and turgor pressure, 
respectively. Neighboring resident cells create and exocytose these molecules to be incorporated 
into the surrounding matrix. In brief, the primary glycosaminoglycans are chondroitin sulfate, 
heparan sulfate, keratan sulfate, and hyaluronic acid. The primary fibrillar components are 
collagen, elastin, fibronectin, and laminin [10]. Beyond the structure that these proteins lend to 
the body, the matrix itself contains embedded cues and site-specific posttranslational 
modifications that dictate behavior and act as "guideposts" to local cells. These cues become 
especially important in situations where the matrix is damaged. In these instances, fragments of 
the broken structural proteins have also been shown to act as chemotactic signals for repair and 
degradation mechanisms [11]. Many of the ECM proteins are actually complex fibrillar structures 
assembled outside the cell from specific components in highly coordinated sequences. The 
creation and incorporation of these proteins into the matrix is spatially specific and is encoded by 
complex genetic processes [12].  
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While dysfunction in these mechanisms accounts for a wide array of arguably rare 
congenital defects including Marphan syndrome, Ehlers Danlos Syndrome, and Alport's 
Syndrome, knowledge of the proper function of ECM protein deposition is crucial to 
understanding the likely mechanisms behind chronic wound deficits [12]. As a brief example, the 
later stages of diabetes are associated with impaired wound healing. It is commonly believed that 
numerous systemic effects are responsible for this deficit, but collagen posttranslational 
modifications may play a role [8]. These molecules, which are mostly pendant disaccharides, are 
known to direct the proper incorporation of the molecule into the matrix as well as signal 
fibroblasts during the repair and deposition process. An increase in interstitial sugar 
concentration, as seen in diabetes, could lead to the polymerization of pendant disaccharides. 
"Masking the guidepost", these changes could affect both the proper creation of collagen fibrils 
and the ultimate incorporation into the matrix itself. Current theory supports that the 
glycosylation of these advanced glycosylated end products (AGE) onto matrix structural proteins 
is also responsible for the downward spiral of inflammation-mediated degradation, resulting in 
chronic wound persistence [8, 13].   
Equally as important as the mechanisms of creation and repair are the functions of the 
ECM proteins, themselves. While the extracellular matrix is composed of countless proteins and 
glycosaminoglycans mixed in varied concentrations at specific locations, perhaps the three most 
important elements by structural and functional contribution in the dermis are collagens, 
fibronectin, and elastin.  
Collagen: The term collagen is perhaps a misnomer, as it refers more to a structural 
domain found in a wide variety of proteins (ranging from the flexible constituent of bone, to the 
neurotransmitter Acetylcholine), rather than a specific protein. Fibrillar collagens, named for the 
long fiber structure commonly known as collagen, dominate the structural components of the 
ECM. Specific collagens are usually spatially localized and are specified by the combination of 
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tropocollagen fibers that make up their triple helical superstructure. The thermal tolerance and 
structural properties are of collagen are due largely to hydroxyproline, a molecule almost unique 
to collagen within the body. Specific combinations of constituent tropocollagens determine the 
function and mechanical properties of the larger collagen fibril. Type I fibrillar collagen is the 
primary structural component of skin, yet Type III fibrillar collagen lends skin its extensible 
properties. Other collagens also exhibit the typical triple helical domains, but do not form larger 
fibrillar structures. Type IV collagen cross-links extensively to form the basal lamina of the skin. 
While low in concentration Type VII collagen plays a critical role in anchoring the basal lamina 
of the skin to underlying structures. [11] 
 
Fibronectin: Fibronectin is an ECM glycoprotein known for its ability to bind integrins, 
collagen, fibrin, and syndecans. When incorporated into the matrix, it exists as a homodimer 
linked by disulfide bridges. Usually secreted by fibroblasts as a soluble dimer, it is later 
incorporated into the matrix directly. Significantly, this protein can link ECM structural 
 
 
Figure 2. The structure and formation of collagen. Left shows the Gly-X-Y repeating structure 
(where X and Y are normally proline and hydroxyproline, respectively). Right illustrates the 
detailed formation of a collagen fibril relative to cellular location. (Alberts et al. 2002) [18] 
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components directly to cells. Subsequently, fibronectins play a significant role in cell adhesion 
and migration. Though many forms of fibronectin exist throughout the body through alternative 
splicing, most are directly associated with cell adhesion to the ECM. Notable is its other soluble 
form, plasma fibronectin, a major constituent of blood manufactured by the liver. Upon tissue 
injury, plasma fibronectin is incorporated into the temporary matrix formed as a clot. Throughout 
the course of wound healing this clot is degraded, and subsequent fibronectin byproducts become 
cellular signals. Research by Valenick et al. suggests that α4β1 integrin binding, crucial to 
cellular contraction and the proper progression of healing, is enhanced by the presence of these 
fibronectin fragments. [11, 14] 
Elastin: Elastin is the protein in connective tissue that confers most of the deformation 
tolerance to skin and other connective tissues. Elastin is composed of tropoelastin monomers 
cross-linked at lysine residues by lysyl oxidase. Elastin is amorphous in structure when relaxed 
due to its mobile hydrophobic regions, but its regular repeats and cross-linked pattern become 
apparent upon stretching. When incorporated into connective tissues and skin, elastin is 
surrounded by a sheath of glycoproteins (primarily fibrillin) forming the overall structure of 
elastic fibers. [15] 
 
Impaired Wound Healing 
Understanding the cellular and structural elements of normal dermal wound healing 
allows for the investigation into situations of mechanistic failure. This review focuses on the 
complex situation of diabetic foot ulcers, while including a somewhat more basic biological 
situation of burn wounds.  
Diabetic Foot Ulcers: Prevalence, Complications, and Possible Causes 
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reports 
that there were 20.8 million diabetic patients in the United States in 2005, representing 7% of the 
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total population and an estimated direct medical cost exceeding $90 billion in 2002 [5]. Long-
term hyperglycemia significantly impairs normal wound healing mechanisms in the diabetic 
population, although the underlying cellular mechanisms of this impairment are largely unknown 
[16]. Advanced diabetic complications (cardiovascular disease, atherosclerosis, and peripheral 
neuropathy leading to numbness) amplify the risk of this impaired wound healing, making 
diabetics increasingly vulnerable to chronic wound formation, especially diabetic foot ulcers, 
which are currently the most common wound care problem in the United States. 
 Bennett et al. conducted a comprehensive review of the underlying mechanisms of 
diabetic foot ulcers, relating these to development of current therapeutics [17]. The two most 
significant risk factors in diabetes that result in foot ulcers are peripheral neuropathy and 
ischemia. Through peripheral neuropathy, changes in gait lead to improper loading, while 
coincidental numbness prevents body's normal feedback mechanism of pain from reporting the 
pattern. Moreover, loss of normal sweating response leads to degradation of skin integrity and 
increased risk of infection over time. Through ischemia (associated with high incidence of lower 
limb atherosclerosis in diabetic patients), low tissue oxygenation can lead to stress and necrosis. 
Recalling that the normal wound healing course, inflammation and signaling is conducted 
through local vascular flow, one can see that ischemic conditions impede subsequent wound 
healing as well. [18] 
  Roughly 20 – 25% of the diabetic population, or 4 – 5 million patients, require treatment 
of foot ulcers at least once in their lifetime, making these lesions responsible for more 
hospitalizations than any other complication from diabetes. These wounds remain in a chronic 
inflammatory state while the body is unable to follow the normal wound healing response, and 
therefore these lesions generally have difficulty healing. Treatment of foot infections requires 
coordinated clinical management with attention to both local and systemic issues [19, 20]. 
Therapeutic strategies used today include repeated debridement, offloading, and dressings for 
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lower grade ulcers, and broad spectrum antibiotics and occasionally limited or complete 
amputation for higher grades, requiring a team effort of health care workers from various 
specialties [21]. Approximately 100,000 limb amputations per year are a direct result of diabetic 
foot ulcers while morbidity from these chronic wounds remains unacceptably high. This figure 
will likely continue to rise given the major public health issue that “diabesity” has become.  
Citing institutions such as the American Hospital Association and reports from the US 
Health Services, reviews of age-related chronic wound prevalence and cost present figures in the 
range of $9-20 billion annually, representing over 5 million patients [7, 22]. Discrepancies in 
these numbers and the relationship between chronic wounds, aging, and disease are directly 
addressed in such reviews as the result of inadequate definition and aspecific diagnosis of a 
chronic wound situation arising from a multitude of concurrent mechanisms. Moreover, these 
numbers are considered to be obscured by the correlation between chronic wound development 
and decreased mobility, leaving a significant population undergoing treatment via home care. The 
ill-posed definition of chronic wounds begets discrepancies in treatment and research 
development. Reviewing clinical cases and outcome measures, Matousek et al. explains that a 
recent interest in more “objective” measures is well placed but slow in progress [4]. He cites that 
outcome measures for therapeutic efficacy in chronic wounds remain largely uncontrolled, and 
that few studies attempt to correlate clinical and laboratory science findings. After declaring 
current gold standards for treatment therapeutics insufficient for translation between scientific 
and clinical application, he calls for a unification of outcome assessment. 
The suboptimal clinical outcome has lead scientists to explore new strategies for limiting 
development of foot ulcers, such as new off-loading techniques and dressings, artificial skin 
grafts, growth factors, and alternate methods of debridement [23]. While the use of some of these 
growth factors has elicited encouraging results in animal models and controlled pilot clinical 
studies, many problems plague these methods in the arena of clinical use. Bennett blames much 
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of the mixed results in clinical trials to small trial sizes and inconsistent endpoints [17]. 
Nevertheless, varying treatment response rates and dosimetry, coupled with short half lives, local 
inactivation, and poor bioavailability through current delivery vehicles are leading researchers 
like Eming and Benn to research alternative transfer vehicles like particle mediated gene delivery 
of growth factors, specifically PDGF (platelet derived growth factor) and TGFβ-1(transforming 
growth factor), to increase delivery efficacy and bypass degradation [24].  Benn showed increase 
in wound tensile strength of both diabetic and nondiabetic rats via particle mediated gene transfer 
with TGFβ-1 cDNA’s [25]. Though also encouraging and not likely as short lived as topical 
applications, they are likely as expensive. Furthermore, these methods bear the limitations and 
risks of treatment efficiencies associated with current gene transfer methods of drug delivery.  
Despite these efforts, early recognition of foot ulcer symptoms and rigorous, continuous 
management remain the most effective strategy in the treatment of diabetic foot ulcers [26]. Thus, 
researchers continue to search for a local or systemic therapeutic strategy that can measurably 
accelerate wound healing in both early and late stages of diabetic wound formation. 
 
Chemical and Thermal Burns 
Burn wound care has become an increasing military interest. Epidemiological studies 
from current military operations in Iraq and Afghanistan indicate a shift to a greater percentage of 
morbidity due to explosion [27]. In current engagements, 81% of the wounds were a result of an 
explosion (improvised explosive device or IED, landmine, mortar, bomb, and grenade) as 
compared to 65% in Vietnam, 73% in WWII, and 35% in WWI [28]. Explosive wound types are 
described in the report as those resulting from pressure waves, penetrating projectiles, blunt 
trauma, and thermal burns. Thermal burn wounds are the most difficult to treat explosion wounds 
in terms of recovery time, pain, infection risk, and cosmetic appearance. The report furthers that 
an increase in the number of improvised explosive devices targeted to vehicles have led to a 
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subsequent increase in thermal burns through secondary mechanisms, including burning vehicles, 
clothing and equipment.   
Skin exposure to severe partial thickness or full thickness thermal burns (and chemical 
burns) can take up to three months to heal [29]. Burn wounds necessitate constant care for full 
recovery. The combination of the physical and chemical changes in tissue leads to the creation of 
a compromised wound periphery that contains large quantity of denatured protein and poor 
circulation. This charred area, called eschar, is a perfect breeding ground for bacteria, and 
subsequent ischemic necrosis in the surrounding area requires a situation of constant physical 
removal (debridement) to ensure proper healing. Though technologies are being developed to 
assist in the treatment of burn wounds, the debridement of eschar is currently a painful 
mechanical process that yields best results with frequency. [30] 
Animal Models of Wound Repair and Analysis Measures 
Much work has been done on advancing the accuracy of animal models for human 
wound repair [31]. Murine models (which dominate in this area by availability of numerous 
genetically modified phenotypes, low cost, maintenance, reagent availability and previous 
research data availability), express phenotypes that are more readily applicable to acute wound 
repair than to chronic wounds. There is difficulty in modeling chronic wounds due to the 
physiologic differences between animal and human repair [31].   
The type of wound inflicted on the animal model directly affects the types of 
measurements that can be conducted as part of the study. Advanced histological image 
processing and biochemical content assays like microarray are more feasible when utilizing full 
thickness excisional wounds (i.e. removal of a significant volume of tissue and the filling of the 
void).  Excisional wounds are usually created with a biopsy punch, and subsequent healing rates 
are monitored as a function of wound volume or cross-sectional area, extent of reepithelialization, 
histological organization, and collagen content. However, the excision of the loosely attached 
14 
skin of rodents leads to significant wound closure by contraction, which results in rapid shrinkage 
of the surrounding skin in a presumably adaptive fashion due the reaction of contractile filaments. 
The presence of contraction reduces wound volume to an extent far greater than what is 
encountered in human wound healing [31]. Contraction creates a source of organism specific 
variation, limiting the extent of granulation tissue, leukocyte infiltration, and reepithelialization, 
all of which are crucial features scored in semi-quantitative histological analyses. Experimentally, 
contraction is readily limited by splinting of the wound with retaining rings.[31] 
Incisional wounds, while easier to create and replicate than excisional wounds, have an 
extremely limited volume of granulation tissue for biochemical analysis as well as a significantly 
smaller histological cross-sectional area. However, incisional measurements offer the distinct 
advantage of biomechanical evaluation via tensiometry. Unlike many measures of wound healing 
dynamics, tensiometry provides quantitative data regarding structural elements of the healing 
wound. In tensiometric experiments, wounds are segmented transversely into strips of defined 
length and width. Using the principles of biomechanics for testing viscoelastic solids, tissue 
samples are test for stress and strain capabilities. Skin samples usually undergo "priming", in 
which they are stretched to a predefined stress or strain two to three times before they are strained 
to rupture. The machine records tensile load, stress, and strain, such that parameters like Young's 
Modulus and the maximum tensile load can then be calculated. While quantitative, tensiometry 
requires sample consumption, precise measurement of sample volume, and precise loading 
technique to yield accurate data.[31] 
Burn wounds, while perhaps the most accurate physiological comparison of impairment 
between species, offer the greatest complexity in creation and management. Reproducibility of 
thermal wound creation poses a significant challenge. Davidson cites the need to fabricate a 
custom instrument derived from a common soldering iron, utilizing stackable weights to ensure 
constant temperature and pressure over a defined time [31]. Accurate modeling and control of 
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subsequent treatments, debridement and wound wrapping procedures must be controlled with 
high scrutiny.  
Chemical burn creation, in addition to wound reproducibility issues, poses a significant 
risk of containment. Moreover, substances causing chemical burns in humans do not always 
affect animal models. One well-characterized model of chemical burn application is the sulphur 
mustard gas burn. Sulphur mustard causes skin blisters and the development of an ischemic burn 
wound in both human and porcine skin. In a recent study or debridement techniques, Evison et al 
described a complex mechanism by which sulphur mustard gas was released within a contained 
glass cylinder pressed to the intended wound site at a known concentration for a specified time, 
and then evacuated by an isolated pump system. [29] 
Impaired wound healing model to mimic complex human pathology pose an even greater 
difficulty than other chronic wounds. Animal models for diabetes can be chemically induced or 
of genetic origin. In murine models, the chemical most commonly used to induce diabetes is 
streptozotocin (STZ). A dangerous but effective chemical, STZ induces rapid development of 
diabetes mellitus by selective destruction of the beta-cells in the pancreatic islets. Mice must be 
fasted at least 12 h prior to injection, and the efficacy of the treatment is highly strain- and dose-
dependent. The life span of mice after successful induction of diabetes is limited (several weeks). 
STZ itself can lead to deleterious effects on macrophage function (known to be part of the wound 
healing mechanism) [31]. STZ diabetic mouse models have been shown to demonstrate decreased 
excisional wound closure, reduced granulation tissue formation, and reduced angiogenesis in 
previous studies. However, the STZ protocol is not suitable for studying the long term effects of 
diabetes.  
Genetic murine models of diabetes pose other difficulties. Arguably, the best 
characterized murine model of type II diabetes is the db/db (C57B/6J background, known to 
greatly influence disease progression). The Jackson Labs (Stock No. 000697) description of the 
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model indicates that a mutation in the leptin receptor gene (Leprdb) leads to polyphagia, increased 
plasma insulin and resulting obesity. Hyperglycemia develops in this model due to 
hypoinsulinemia and loss of beta cell mass [32]. Widely used as a model of diabetic wound 
healing, the db/db was shown to exhibit deficiencies in cell-mediated immunity as early as 1978 
[33]. Recently, it has been popular in research regarding the topical application of growth factors 
to model incisional and excisional diabetic wounds [34-36]. While models of type II diabetes are 
commonly used due to high physiological relevance, reasonably long life span, and subsequent 
applicability to long- term hyperglycemia-related complications, these mice have a high tendency 
to be morbidly obese. The dermal fat deposits in loose rodent skin affect the normal mechanisms 
of closure, creating their own impediment to healing, which affects the accuracy of impaired 
healing endpoints and requiring the exclusion of mice that become morbidly obese [31].  
A non-obese genetic murine model for diabetes mellitus, dubbed the Akita mouse may be 
more useful to study biochemical and histological aspects of diabetic wound healing. The Akita 
mouse shows advantage of early onset of impaired insulin secretion, decreased active beta cell 
numbers, and a 50% survival time of 305 days [37]. Due primarily to its non-obese 
characteristics, the Akita mouse has been commercially developed and is now publicly available 
through The Jackson Labs (Stock No. 002207). This model is intended for study of insulin-
dependent diabetes mellitus with severe hyperglycemia, further indicating that the model is also 
accurate for study of diabetic effects on growth factors [38]. Several in depth studies of secondary 
effects of diabetes by Breyer et al. have used the Akita mouse to model diabetic nephropathies 
with notable success [39]. In a study by Gyurko et al. , chronic hyperglycemia in Akita mice 
showed decreased leukocyte function and increased inflammation. This study speculates that the 
superoxide production of mitochondria in chronic hyperglycemia contributes to the endothelial 
damage essential to the long term complications of diabetes. The presence of defects related to 
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diabetic wound healing impairment strongly supports the use of the Akita mouse model in 
diabetic chronic wound healing [9].  
Despite the many advantages of the murine model in reagent availability and both 
pharmacological and genetic manipulation, the murine model lacks key physiological similarities 
to human skin. As a more relevant alternative, porcine skin has dermal architecture, vascularity 
and hair follicle densities, and (nonfunctional) sweat glands similar to human skin [30]. 
Excisional wounding in the pig produces a limited degree of contraction, in contrast with the 
dominant effect of this process in murine excisional wounds [31]. In terms of an impaired or 
chronic wound healing model, however, the pig presents a greater challenge.  While specific 
chemically diabetic pig models (via STZ or alloxan; similar to murine models above) exist and 
are commercially available (Sinclair Research, Maine), the presence and extent of wound healing 
impairment, if any, in available diabetic pig models has not yet been characterized [40]. Most of 
the research cited for these models analyzes vascular changes due to diabetes [41-43]. 
Glucocorticoid administration offers a viable alternative to induced diabetes in the porcine model 
that has been used effectively used in studies of impaired cutaneous wound healing in the pig [44, 
45]. Glucocorticoids, while known for their anti-inflammatory activity, are also associated with 
skin thinning and decreased healing capacity, likely due to interference in monocyte 
differentiation into signaling macrophages or fibroblast collagen synthesis [31].  
Ultimately, when studying impaired or chronic wound healing, choice of an animal 
model is crucial. Precise research scope limitations must be defined before an appropriate model 
can be selected. Unfortunately, many of the models well-characterized in the literature were 
developed for the study of pathologies unrelated to cutaneous wound healing. Furthermore, 
knowledge of the precise mechanisms of wound healing and suspected pathologic basis of 
impairment is crucial to selecting a model that can yield applicable results. 
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Enhanced Wound Healing 
Recent work in wound healing has seen a certain degree of paradigm shift from the 
attempted shutdown of natural bodily mechanisms to a situation in which therapies are attempting 
to increase or stimulate the activity of known pathways. The majority of treatments currently in 
development to enhance wound healing, especially targeted towards the impaired or chronic 
wound, are based on the use of topical gels containing potent mixtures natural wound healing-
associated growth factors. In a review about the use of growth factors in ulcer treatment, Bennett 
concludes that limited numbers for human trials as well as inconsistent endpoints between trials 
preclude drawing any firm conclusions. These mixed results are not surprising given the precise 
regulation in time and space of growth factors and cytokines associated with normal wound 
healing. Bennett also cites that the best treatment method available is still traditional care and 
mechanical debridement, but that expensive gel-based treatments may eventually offer a 
significant alternative despite cost due to revascularization results [18]. Other significant efforts 
have also led to the creation of extended release gels and compounds that target the chemical 
acceleration of debridement, in an attempt to decrease the loss of healthy tissue lost to traditional 
mechanisms [30].  
 
Lasers for Wound Healing Enhancement  
While most efforts focus on the use of results from the mechanistic studies of wound 
healing to create chemical compounds to aid healing or prevent deleterious byproducts of chronic 
wounds, some work focuses on the upregulation of natural pathways without the addition of 
potent chemical substances. In these methods, lasers are used as a source of non-contact dermal 
heating through the selective absorption of light. While indubitably less expensive in long term 
care than the exogenous development and topical application of growth factors, the thermal 
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regulation of wound healing mechanisms is also arguably more customizable to meet specific 
patient needs.  
A series of studies by Beckham et al. and Wilmink et al. indicate that optimized doses of 
laser light are sufficient to upregulate the induction of stress protein HSP70 (heat shock protein 
70). The studies utilized bioluminescent imaging to optimize the dose of light that maximized the 
heat shock protein induction. The treatment has been shown to protect against subsequent thermal 
injury, and accelerate the healing of subsequent cutaneous wounds. Analysis indicated increased 
maximum wound tensile load, cellular proliferation, increased local circulation.[46, 47]   
Confirming the induction of HSP 70 in laser dermal treatments, work by Capon et al. and 
Souil et al. focused more on a treatment designed to accelerate wound closure with endpoints 
aimed toward the structural and cosmetic benefits of minimal scarring after surgery [48-50].  
While the former is likely more applicable to the treatment of impaired wound healing scenarios, 
the latter confirms the applicability of the treatment after the creation of the wound. Despite 
confirmation of the presence of HSP70, and correlation between its upregulation and enhanced 
dermal wound healing, the mechanism behind the action of the treatment is unknown.   
Unlike other methods for inducing tissue heating, lasers allow fast heat deposition, 
uniform heat distribution, and therefore highly controlled spatial-temporal tissue heating. In 
addition, laser energy can be delivered through optical fibers, allowing for high precision heating 
and relative ease of use. While one could reasonably argue that the same thermal induction and 
subsequent HSP 70 induction could be achieved by inexpensive contact methods, the physical 
contact required for conduction is not optimal for the treatment existing ulcerated or burn 
wounds. In contrast, laser light can be delivered in non-contact fashion, thus mitigating risks of 
infection and pain due to contact with an open wound.  
Lasers provide more than simply a non-contact heating method. In the context of thermal 
enhancement of dermal wound healing, lasers function through a principle of selective 
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absorption. Tissue chromophores, molecules that absorb light, each have an intrinsic absorption 
spectrum, such that the probability of light absorption by a given chromophore depends directly 
on the wavelength, in a manner that can accurately be modeled by simulation [51]. This absorbed 
energy is converted to heat, which diffuses according to tissue physical and thermal properties 
[52]. For successful thermal enhancement, the laser parameters must be matched to both tissue 
optical and physical properties [53]. With proper understanding of the properties and mechanisms 
of laser-tissue interactions, laser treatments can be tailored to generate a desired "dose" of light 
and control subsequent heat generation as a function of time and space. These treatments can then 
be optimized to ensure desired heating while minimizing tissue damage.  
 
Heat Shock Proteins in Wound Healing 
Cellular responses to thermal stress involve complex pathways that are noted for their 
transcriptional activation of heat shock protein (HSP) genes. Transcriptional activation can be 
seen immediately after thermal insult and follows a characterized time course. A large family of 
diversified proteins, HSP's are ubiquitous and conserved in most species [54-57]. HSP's have 
been shown to maintain cellular homeostasis through mechanisms involving new protein folding 
and refolding of denatured protein.  
The very process of transcription places nascent proteins at risk. During synthesis, newly 
formed segments of protein have not yet folded to achieve entropically favorable charge balance. 
HSP's shield highly hydrophobic linear regions of transcribed polypeptides, preventing 
interaction with cytosolic proteins and the subsequent aggregation that prevents functional 
folding [58].  Through similar methods, HSP's assist in the refolding of denatured proteins. 
Though explained to a lesser extent, loss of cytosolic protein function through chemical or 
thermal denaturation leads to the upregulation of HSP's. The cylindrical domains of the HSP 
envelope the denatured protein, providing an environment favorable to proper refolding [58]. 
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Through molecular mechanisms involving mitochondrial signaling and caspase-3, HSP's are also 
responsible for protective processes, shielding cells from subsequent injury and apoptosis (see 
Figure 3) [59]. For these reasons, HSP's are widely considered a primary family of "chaperone" 
proteins.  
C.
A. B.
 
 
Figure 3. The molecular pathways and regulations of prominent HSPs. A indicates the 
activity of multiple HSPs in the prevention of three prominent apoptotic cascades between 
the cell-surface receptor binding level and the mitochondrial signaling level [59]. B 
highlights the involvement of HSPs subsequent to mitochondrial signaling, affecting both 
caspase dependent and caspase independent apaoptotic pathways [59]. C illustrates the 
upregulation mechanism of HSP70 through HSF1 in response to protein denaturation [63. 
64]. 
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Of particular interest, HSP70 exists in most cells under normal condition, but is noted for 
its highly inducible expression kinetics, cited as high as 15% of cellular protein content [60]. 
Unlike other HSP's, HSP70 lacks a cylindrical domain, and is instead considered a holding 
protein that participates in refolding through the temporary binding of short amino acid 
regions[58]. HSP70 is known to refold unfolded proteins through ATP cycling mechanisms [58, 
61]. The complicated mechanism of HSP70 upregulation suggests how the protein helps protect 
from repetitive insult. Under normal conditions HSP70 is complexed with its own heat shock 
transcription factor, HSF1. Under stress, HSP70 releases from complex to participate in 
refolding, while allowing HSF1 to participate in transcription (see Figure 3.C) [62].  Upon 
completion of refolding, HSP70 again complexes with HSF1, providing feedback inhibition and 
an increase in the stable population of HSP70 [63, 64]. The protective mechanisms of HSP70 are 
closely associated with the cell life cycle and the control of apoptosis (see Figure 3). The 
induction of HSP70 has been shown to inhibit cell death and promote cell survival in response to 
insult [65-68].  
Beyond response to thermal insult, HSP upregulation by inflammatory cells has been 
shown during early wound healing, speculated to be a protection mechanism against oxidative 
stress [69]. In impaired wound healing conditions, HSP70 induction is substantially diminished 
[70]. The coordination between HSP's and inflammation has been thoroughly studied, but no 
definitive mechanism of action has been determined. HSP activity is known to correlate to 
decreased activity of well-characterized pro-inflammatory mediators including IL-1β and 
TNFα.[71]. Various key biological chemicals have been shown to modulate HSP activity, 
including prostaglandins and many non-steroidal anti-inflammatory agents [72, 73]. Though 
HSP's and HSP70 in particular have been shown to have protective effects related to wound 
healing, their regulation is clouded by complex overlapping pathways at the heart of cell survival. 
Though it will be difficult to experimentally determine a mechanism of action for a protein so 
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integral to cell survival (many interacting proteins listed will not yield viable knockouts), 
understanding how this protein family enhances wound healing will be crucial to the use of HSP 
modulation to improve impaired wound healing through intrinsic mechanisms. 
 
Optical Analysis of Wound Healing: Raman Spectroscopy 
In the efforts to determine mechanisms of impaired and enhanced dermal wound healing 
to increase treatment efficacy, the current standard measurements in pathology studies 
(tensiometry, histology, and biochemical assays) would require a significant amount of animal 
sacrifice, while resulting data would be based on the underlying assumptions that the response 
shown throughout several time points is the same between organisms. Moreover, these methods 
of data collection, though well established in the literature, do not translate to clinical studies. 
The use of an optical spectroscopy may be able to effectively eliminate those variables while 
gathering an in vivo spatial-temporal localization of biochemical content, through techniques that 
are currently used clinically.  
Raman scattering is an inelastic scattering phenomenon that occurs when a photon 
scatters off an anisotropic chemical bond, resulting in a vibrational level energy change and a 
subsequent shift in wavenumber (see Figure 4.e,f) [74]. Because the energy change is dependent 
upon the chemical bond encountered and not a function of initial photon wavelength, Raman 
Spectroscopy (RS) offers a distinct advantage over other optical spectroscopic modalities, in that 
it yields the same information regardless of input wavelength. However, Raman scattering is 
probabilistically unlikely relative to other light-tissue interactions and suffers under the burden of 
needing high collection efficiency and interference from other interactions including 
fluorescence. Careful choice of wavelength sources and established preprocessing algorithms 
allows for the elimination of interference and the construction of a spectrum of Raman 
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wavenumber shifts. Such a spectrum naturally represents the biochemical distribution of bonds 
encountered in the sample.  
The use of Raman Spectroscopy as an optical tool has been developed for decades in the 
field of analytical chemistry, especially for the examination of pharmaceutical quality [75]. 
During this time, interest in using Raman to analyze biological compounds grew, but efforts were 
largely limited by technological capability. The analysis of purified compounds, molecules, and 
cultured cells indicated that Raman was sensitive to conformational changes and capable of 
distinguishing features of biochemical content. Raman spectra of nucleic acids were sensitive to 
DNA conformational forms (A,B,C, and Z), backbone organization, and the relative contributions 
of specific base pairs, even distinguishing differences in phosphate stretching between DNA and 
RNA [74].  Developments of near infrared (NIR) laser sources designed for Raman spectroscopy 
Figure 4. Jablonski Diagram of Vibrational Spectroscopies: a one-photon electronic absorption; 
b fluorescence; c two-photon electronic absorption; d Rayleigh scattering; e Stokes Raman 
scattering; f anti-Stokes Raman scattering; g one-photon vibrational absorption; h intersystem 
crossing (NRT); i phosphorescence; j internal conversion (NRT) 
*NRT: Non Radiative Transition   
Adapted from Iari-Gabriel Marino's "Vibrational Spectroscopy" at 
http://www.fis.unipr.it/~marino/08_spectroscopy.html 
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minimize the impact of tissue fluorescence on collection, allowing for feasible application to a 
wide variety of biomedical problems; however, relatively few have pursued the use of Raman 
Spectroscopy to tissue applications or in vivo studies [76-78].  
Several specialized tissues make ideal environments for the use of RS as a quantitative 
measure of disease. Römer et al. have pursued the use of NIR Raman for the study of arteries and 
atherosclerosis [79]. The artery itself is composed of distinct, relatively homogeneous layers in 
the absence of atherosclerotic disease. Crucially, the progression of atherosclerotic disease is not 
based upon the size or shape of lesions, but more importantly a function of content. Ultimately, 
their classification algorithm was able to correctly classify 64 out of 68 samples as a function of 
cholesterol content and calcified salts. Analysis also indicated the ability to deconvolve the 
Raman spectra to estimate the relative contribution of diseased and normal components, 
confirming Raman Spectroscopy sensitivity and providing quantitative measures of plaque 
content [79].  
The investigation of bone and related hard tissue provides an idyllic match to the 
strengths of RS. Bone is composed primarily of hydroxyapatite crystals and collagen, making it 
relatively pure in comparison to many soft tissues; however, slight variations of composition and 
formation lead to significant changes in functional strength and risk for failure. The narrow 
spectral features of RS, coupled with the detection of both inorganic and organic components, 
allows for detailed analysis of mineral-matrix interactions. Studies of the Raman spectra of bone 
have been conducted for disease states, growth and repair, as well as for the evaluation of 
synthetic biomaterials [80]. More recently, RS has even been used to investigate the effect of 
differential genetic expression on bone development through mouse model knockout of matrix 
metalloproteinases [81].  
While the strengths of Raman Spectroscopy match analysis needs of certain pure or 
specialized tissues, the analysis of heterogeneous soft tissues provides a greater challenge. The 
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increase in heterogeneity broadens many spectral features, while potentially increasing the 
number of fluorophores obscuring the signal. Nevertheless, the use of NIR Raman spectroscopy 
has led to significant success in the diagnosis of complex diseases including breast and cervical 
cancer [72, 74, 77, 82-84]. A novel statistical method for multiclass analysis of Raman spectra 
developed in our lab combines the method of maximum representation and discrimination feature 
(MRDF) to extract diagnostic information with sparse multinomial logistic regression (SMLR) to 
classify spectra based on nonlinear features [85]. In a recent study of cervical dysplasia, this 
method correctly classified 95% of high-grade spectra and 74% of low-grade data, with both 
sensitivity and specificity above 95% [85]. 
Owing perhaps to accessibility, the study of skin using Raman Spectroscopy is also 
largely motivated by the numerous debilitating skin diseases that could be properly treated or 
even cured if diagnosed or assessed early in development. Skin lesions are usually isolated and 
often non-invasive, but rare invasive cases are highly infiltrative and can require surgical 
intervention. The development of confocal and fiber optic Raman instrumentation represents the 
potential for real-time surgical guidance, and subsequent decreases in procedure cost and patient 
recovery time [76, 86]. Raman Spectroscopy has also been used to correlate the putative 
antioxidant role of skin carotenoids to cancerous lesion prevention [87]. In cosmetic applications, 
confocal Raman microspectroscopy has been used in vivo to demonstrate a depth-dependent 
distribution of natural moisturizing factor, a well-characterized byproduct of enzymatic 
degradation to preserve moisture in the stratum corneum in dry environments [86]. The diversity 
of successful applications of Raman Spectroscopy to skin supports the hypothesis that Raman 
Spectroscopy could viably be used for in vivo analysis of cutaneous wound healing. 
Despite the possibility of a natural extension of ongoing studies in bone or skin, 
remarkably few research groups have pursued the investigation of wound healing or tissue repair 
using optical spectroscopies. Zhang et al. utilized the relative strengths of both Infrared (IR) 
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Spectroscopy and confocal Raman spectroscopy to visualize the keratin-rich reepithelialization 
front and the spatial distribution of elastin and collagen within the wound bed, respectively [88]. 
Chan et al. analyzed an ex vivo human skin wound culture model with IR and confocal Raman 
spectroscopies over several days. Subsequent deconvolution of confocal mappings using factors 
with distinct elastin and collagen features allowed for spatial-temporal distribution of major 
structural proteins [89]. Crane et al. presented at the 2008 conference of the Federation of 
Analytical Chemistry and Spectroscopy Societies (FACSS) about Raman studies of wound 
biopsies from soldiers, demonstrating qualitative differences between healing and chronic wound 
spectra [90]. Alimova et al. analyzed the changes in spectral content as a function of incisional 
wound closure via traditional suture or experimental laser tissue welding from two different 
lasers at discrete time points in the healing process of four guinea pigs [91]. This work differs 
from other reports of spectroscopic wound healing in several ways. The Raman spectroscopy 
acquisition protocol for this study utilizes irradiances and collection times currently approved for 
clinical study. This work represents the first known report of Raman sensitivity to spectral 
differences in the healing wound and neighboring tissue as a function of both genetic expression 
as well as treatment response. 
The collection of a clinically relevant, in vivo profile of healing wounds was possible due 
to unique system design. The use of Raman Spectroscopy coupled to microscope systems has 
been used at length to examine histological sections in vitro with existing commercial systems 
[75]. However, our lab utilizes a fiber optic probe design in combination with a fast acquisition 
protocol and automated pre-processing to make a portable, clinically feasible Raman system. The 
portable Raman system consists of a mode locked diode laser (λ=785nm; Innovative Photonic 
Solutions, Mammoth Junction, NJ) coupled to a custom fiber optic probe (7 collection fibers 
surrounding an excitation fiber; Emvision, Loxahatchee, FL). 80 mW power output from the 
excitation fiber provides sufficient signal at irradiances that do not induce significant heating of 
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the tissue. Collection fibers are coupled to a f /1.8 holographic imaging spectrograph (Kaiser 
Optical Systems, Inc., Ann Arbor, MI), subsequently focusing light onto a back-illuminated, deep 
depletion, thermo-electrically cooled Andor Newton CCD (Andor Technologies plc., Belfast, 
UK). For most skin applications, each Raman scan consists of 3 accumulations of 3 second 
exposures of the CCD to ensure maximum signal without saturation.  
Many biological substances can be detected as an intensity "fingerprint" of Raman shift 
peaks [75]. Complexity increases in living tissue, given the presence of numerous fluorophores. 
Once the isolated Raman shift spectra have been obtained, the relative concentrations of 
individual "Raman active" species can be detected. Occasionally, specific diagnostic peaks can be 
isolated to indicate the presence of pathological effect or the relative concentration (intensity) of 
an important protein. In thoroughly characterized situations, a library of peak signatures 
indicative of known prevalent molecules is used in combination with advanced regression 
analysis to deconvolve the composite Raman signal into relative concentrations [92, 93].  
In the use of Raman spectroscopy for wound healing analysis, such that no specific 
substance indicative of normal or impaired wound healing is yet known, the latter technique may 
be required. The review of ECM proteins represents the major volume constituents of the 
acellular components of skin. These will likely be responsible for a large portion of the signal 
observed in vivo. Given that many of these proteins have similar repeating structural domains, 
and differ primarily in posttranslational modifications and functionalized ends, the isolated 
Raman spectra of these substances would be invaluable in determining differences in the 
progression between normal, impaired, and enhanced wound repair. A broad bank of literature 
supports the assignment of Raman wavenumbers to chemical bonds related to inflammation and 
extracellular matrix proteins due to their relevance to cancer studies [74, 84, 94, 95], 
subsequently allowing for ease of analysis in related wound healing parameters.   
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One of the primary obstacles to measuring Raman spectra of the healing wound will be 
obtaining information below the highly absorptive scab region. Spatially Offset Raman 
Spectroscopy (SORS) operates on the probabilistic principles of light scattering that correlate 
translational path length to the average depth reached by the scattered photon. Over a large 
number of photons, the further the photons are collected from the source of incidence, the deeper 
the level of biochemical information resolved [75]. SORS may help to collect the necessary 
information to determine the biochemical content of a healing wound. 
Summary 
In this thesis, I demonstrate the use of Raman Spectroscopy as a quantitative analytical method to 
assess the role of HSP70 in incisional wound healing, as well as the relationship between HSP70 
and a previously established laser preconditioning protocol. The overall goal of this thesis is to 
determine whether HSP70, previously used only as a biomarker for optimization, plays an active 
role in the mechanism of laser preconditioning therapy. The specific aims include: establishment 
of a Raman spectral profile of murine incisional wound healing; assess differences in the wound 
healing profile as a function of hsp70; quantification and qualification of downstream effects of 
laser preconditioning through spectral profile analysis. The next chapter of this work delineates 
the specific methods and results of the experimental study. The final chapter will provide a 
detailed discussion of the scope of both the results and conclusions of the study, as well as future 
directions for this work. The success of this work not only suggests the degree of involvement for 
HSP70 in wound healing and laser preconditioning, but it also implies the potential of Raman 
Spectroscopy as quantitative method for the diagnosis of wounds and noninvasive assessment of 
treatment response. 
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Abstract: 
Laser preconditioning augments incisional wound healing by reducing scar tissue and 
increasing maximum tensile load of the healed wound. While the exact role of HSP70 in this 
process has not been clearly elucidated, it is well established that HSP70 expression is correlated 
with thermal stress and subsequent repair as part of the thermal (pre)conditioning response. 
Recent studies have optimized treatments or confirmed results using HSP70 as a biomarker. 
Under the hypothesis that HSP70 plays an active role in reported results and to better understand 
the downstream effects of laser preconditioning, this study utilized a probe-based Raman 
spectroscopy system to achieve an in-vivo, spatio-temporal biochemical profile of murine skin 
incisional wounds as a function of laser preconditioning and the presence of HSP70. Raman 
spectra yielded significant differences (t-test; α=.05) in several known biochemical peaks 
between wild-type (WT) and HSP70 knockout mice on wounds and in adjacent tissue early in the 
wound healing process. Analysis of peak ratios indicated 1) an increase in protein configuration 
on and surrounding the wound, and 2) increased cellularity that was prolonged in WT mice due to 
laser treatment. Polarization microscopy confirmed that laser treated WT mice showed increased 
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heterogeneity in collagen orientation. HSP70 is active in protein configuration and cellularity of 
early wound healing. Laser preconditioning enhances the effects of HSP70 in ways consistent 
with findings of previous studies. Raman spectroscopy proved a convenient non-invasive method 
of obtaining information for evaluating these effects and efficacy of wound healing laser 
treatment. 
 
1. Introduction: 
Wound repair is a complex coordinated sequence of overlapping biochemical and cellular 
events that result in the restoration of damaged tissue [1]. Under normal conditions of wound 
repair, the processes that result in healing of injured tissue follow a specific and well-defined time 
course. Various disorders, including diabetes and burn wounds, create conditions that impair the 
normal sequence of wound repair [2] causing many patients to eventually develop chronic 
wounds [3, 4]. High mortality rates and a growing number of limb amputations, roughly 100,000 
per year in the US alone from diabetic foot ulcers, have sparked investigation into a variety of 
novel preventative and treatment strategies for enhancement of wound healing.   
In one such method, researchers have shown that pre-treating cells or tissues with an 
initial mild thermal stimulus (often referred to as preconditioning), elicits a stress response that 
can serve to protect the tissue from subsequent lethal stresses [5-7]. There is evidence that heat 
shock proteins (HSP’s) are largely responsible for this preconditioning phenomenon. While a 
variety of tissue heating methods have been used, preconditioning results using laser irradiation 
have been proven to be most effective due to the uniform and controlled temperatures induced in 
cells and tissue. Moreover, laser-based approaches provide the ability to induce tissue heating in a 
non-contact fashion (unlike metal contact probes) which in turn is expected to reduce pain and 
mitigate the risk for infection. Recent results demonstrate that laser preconditioning tissue 6-12 
hours prior to cutaneous injury (scalpel incision and laser ablation) significantly accelerates 
wound healing yielding greater tensile strength and improved cosmetic outcome [8]. It was shown 
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that 1) HSP70 upregulation is required for a efficient preconditioning response [9]; and 2) HSP70 
is a useful biomarker for therapeutic efficacy of improved wound healing after tissue 
preconditioning [8]. Using Bioluminescence imaging (BLI), a novel molecular imaging approach, 
optimization of HSP70 expression was possible. Since the promoter sequence for HSP70 drives 
expression of optically active reporter genes (luciferase and GFP) in a transgenic mouse, BLI 
enabled real time quantification of the efficacy of tissue preconditioning in vivo without the need 
to sacrifice the model for histological analysis. By quantifying HSP70 over time, the 
preconditioning protocol has been optimized for normal tissues prior to wound induction.  
While the exact role of HSP70 has not been clearly established, it has been shown that 
HSP70 expression is correlated with thermal stress and subsequent repair as part of the thermal 
(pre)conditioning response. In normal wound repair, HSP70 is rapidly induced but in the chronic 
wound setting, HSP70 is decreased [10]. Thus it is logical to hypothesize that a thermal 
modulation protocol will elevate basal levels of HSP’s and result in accelerated physiologic repair 
of the chronic wound.  
However, in order to translate the preconditioning protocol to a clinically relevant 
thermal modulation protocol, development of a noninvasive, in vivo method that is capable of 
analyzing tissue biochemistry is of critical importance. Such a technology will be required to 
optimize laser preconditioning parameters. Raman spectroscopy utilizes the vibrational level 
energy change of laser light as it scatters off chemical bonds to provide a molecular-specific 
biochemical fingerprint, the analysis of which can be automated to provide realtime information 
of the tissue state. Conventional Raman Spectroscopy (RS), as used for in-vivo applications, 
utilizes a fiber optic probe design in combination with a fast acquisition protocol and automated 
pre-processing. Such a system could be used for treatment optimization as well as clinical wound 
healing analysis. Spectral markers allow for optimization of laser treatment effects on the healing 
wound, while providing tissue level information about the wound itself.  
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Raman Spectroscopy has been used for decades in the field of analytical chemistry, 
especially for the examination of pharmaceutical quality [11]. The analysis of purified 
compounds, molecules, and cultured cells indicated that Raman scattering is sensitive to 
conformational changes and capable of distinguishing features of biochemical content. Raman 
spectra of nucleic acids are sensitive to DNA conformational forms, backbone organization, and 
the relative contributions of specific base pairs, even distinguishing differences in phosphate 
stretching between DNA and RNA [12].   
Developments of near infrared (NIR) laser sources designed for Raman spectroscopy 
minimize the impact of tissue fluorescence on collection, allowing for feasible application to a 
wide variety of biomedical problems; however, relatively few have pursued the use of Raman 
Spectroscopy to tissue applications or in vivo studies [13-15]. Several tissues, including arterial 
tissue [16] and bone [17, 18], make ideal environments for the use of RS as a quantitative 
measure of disease. Despite the greater challenged posed to the use of RS in heterogeneous soft 
tissues (broadened spectral features, increase in fluorophore concentration), the use of NIR 
Raman spectroscopy has led to significant success in the diagnosis of complex diseases including 
breast and cervical cancer [12, 14, 19-23]. 
Owing perhaps to accessibility, the study of skin using Raman Spectroscopy is also 
largely motivated by the numerous debilitating skin diseases that could be properly treated or 
even cured if diagnosed or assessed early in development. The development of confocal and fiber 
optic Raman instrumentation represents the potential for real-time surgical guidance, and 
subsequent decreases in procedure cost and patient recovery time [13, 24]. Raman Spectroscopy 
has also been used to correlate the putative antioxidant role of skin carotenoids to cancerous 
lesion prevention [25]. In cosmetic applications, confocal Raman microspectroscopy has been 
used in vivo to demonstrate a depth-dependent distribution of natural moisturizing factor, a well-
characterized byproduct of enzymatic degradation to preserve moisture in the stratum corneum in 
dry environments [24]. The diversity of successful applications of Raman Spectroscopy to skin 
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supports the hypothesis that Raman Spectroscopy could viably be used for in vivo analysis of 
cutaneous wound healing. 
Despite the possibility of a natural extension of ongoing studies in bone or skin, 
remarkably few research groups have pursued the investigation of wound healing or tissue repair 
using optical spectroscopies. Zhang et al. utilized the relative strengths of both Infrared (IR) 
Spectroscopy and confocal Raman spectroscopy to visualize the keratin-rich reepithelialization 
front and the spatial distribution of elastin and collagen within the wound bed, respectively [26]. 
Chan et al. analyzed an ex vivo human skin wound culture model with IR and confocal Raman 
spectroscopies over several days. Subsequent deconvolution of confocal mappings using factors 
with distinct elastin and collagen features allowed for spatial-temporal distribution of major 
structural proteins [27]. Crane et al. demonstrated qualitative differences between healing and 
chronic wound spectra from wound biopsies of soldiers [28]. Alimova et al. analyzed the changes 
in spectral content as a function of incisional wound closure via traditional suture or experimental 
laser tissue welding from two different lasers at discrete time points in the healing process of four 
guinea pigs [29]. This work reported in this thesis differs from other reports of spectroscopic 
wound healing in several ways. The Raman spectroscopy acquisition protocol for this study 
utilizes irradiances and collection times currently approved for clinical study. Secondly, this work 
represents the first known report of Raman sensitivity to spectral differences in the healing wound 
and neighboring tissue as a function of both genetic expression as well as treatment response. 
This study seeks to confirm an active role for HSP70 in untreated and laser 
preconditioned wound healing by detecting in vivo differences in downstream biochemistry via 
Raman spectroscopy. The novelty of this study lies in the clinical and laboratory relevance of the 
methods, allowing for possible future integration and optimization of subtle laser preconditioning 
treatments, as well as the investigation and early diagnosis of altered wound healing. Towards 
achieving these goals, 19 wild-type (WT) and HSP70 knockout (HSP70-/-) C57BL/6 mice 
underwent normal and laser preconditioned incisional wounds. Daily collection of a spatial 
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distribution of Raman spectra built a time course for the changes in wound healing progression, 
while the analysis of peak ratios highlighted the suggested biochemical relevance of these 
differences due to genetic expression of HSP70 and the response to laser preconditioning 
treatment. The results of findings via RS were then qualitatively confirmed using standard and 
polarization microscopy. Ultimately, Raman Spectroscopy achieved a clinically relevant, non-
invasive, in-vivo, spatio-temporal biochemical analysis of murine skin incisional wounds as a 
function of laser preconditioning and the presence of HSP70. 
 
2. Methods: 
2.1 Mouse Model and Preparation: 
A pre-conditioning and wounding protocol as described below was followed using 
C57BL/6 mice under the approval of and conducted in accordance with procedures established by 
the Vanderbilt Institutional Animal Care and Use Committee (IACUC). HSP70 knockout mice 
were the model described by Hunt et al. [30], acquired through the Mutant Mouse Regional 
Resource Centers (B6;129S7-Hspa1a/Hspa1btm1Dix/Mmcd). $Nineteen adult female mice, 10 
wild-type (WT) and 9 HSP70 knockout (HSP70-/-), were anesthetized with isoflurane. While 
under anesthesia, dorsal fur was clipped and remaining fur was removed using depilating cream. 
The affected area was then repeatedly rinsed and wiped down with alcohol wipes to prevent any 
undesired reaction. Mice were then returned to animal care and observed for 36-48 hours, during 
which any observation of inflammation, pigmentation in the area to be treated, superficial 
wounds, or chemical reaction, resulted in exclusion of those animals from the study.  
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Upon routine inspection no less than 24 hours prior to treatment, the dorsal skin of 
anesthetized mice was cleaned and disinfected, and target areas were surrounded with a series of 
manually created tattoos to ensure consistency of location both throughout preconditioning, 
surgery, and wound healing analysis. Tattoos were placed just below the epidermis using 28 
gauge needles with India ink no less than 1 cm away from the target location. To prevent bias due 
to anatomical variation, contralateral target locations were consistently chosen 1-1.5 cm caudal to 
the base of the skull and centered 0.8-1cm lateral from the spine. Any improper tattooing or 
spreading of ink was considered grounds for study exclusion. 
 
Figure 1. Diagram of mouse model dorsum wound and Raman spectra collection location 
indicates grouping by anatomical locations and subsequent similar biochemical trends: 
Intact skin adjacent to wounds (solid black); lateral wound samples (solid red); medial 
wound samples (dashed blue). Dotted black sample along the spine were used to help 
establish stability of skin spectra as a function of spatial location and hair regrowth but not 
directly used in analysis. 
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2.2 Laser Preconditioning and Surgery: 
Twelve hours prior to surgery, anesthetized mice underwent laser preconditioning on one 
of the two target dorsal locations. Preconditioning location was randomly selected via coin toss. 
Preconditioning protocol was conducted with an Aculight Renoir diode laser (Renoir; Lockheed 
Martin Aculight, Bothel, WA) coupled into a 600 µm diameter,  multimode silica fiber according 
to Wilmink et al. (λ=1.85µm,  Ho=7.64mJ/cm2, spot diameter=5mm, Rep. rate=50Hz, τp =  2ms,  
exposure time = 10 minutes) [8]. During laser exposure, tissue temperatures were measured in 
real time using an infrared camera sensitive to changes of ± 0.1°C (A20 series, FLIR Systems, 
Portland, OR). ThermaCAM Researcher 2.8 was used to record temperature traces and conduct 
data analysis. In assuring consistency with results from Wilmink et al. [8], generated temperatures 
were verified to be approximately 43-44.5°C. 
Twelve hours after preconditioning, mice were once again anesthetized with isoflurane. 
To achieve sterile conditions and prevent the influence of infection, the surgical area was 
cleansed with povidone-iodine solution and alcohol wipes. Using tattoos as guides, two 
contralateral 1 cm full-thickness linear incisions were made with a #11 scalpel blade. 
Immediately after the incision, two 7.5 mm Michelle clips were used to close each end of the 
wound, ensuring the proper opposition of wound edges. Clips were subsequently removed on 
post-operative day 5 (POD5). 
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2.3 Raman Spectroscopy: Acquisition and Processing: 
The portable Raman system consists of a mode locked diode laser (λ=785nm; Innovative 
Photonic Solutions, Mammoth Junction, NJ) coupled to a custom fiber optic probe (Emvision, 
Loxahatchee, FL). This probe consists of a single, central 400μm diameter excitation fiber 
surrounded by 7 equally spaced 300μm diameter collection fibers with in-line filtering to reject 
785nm. Power output from the central excitation fiber was confirmed at ~80 mW for each scan. 
Collection fibers were coupled to a f /1.8 holographic imaging spectrograph (Kaiser Optical 
Systems, Inc., Ann Arbor, MI), subsequently dispersing light onto a back-illuminated, deep 
depletion, thermo-electrically cooled CCD (Model# 920- BRD, Andor Technologies plc., Belfast, 
UK). Each Raman scan consisted of 3 accumulations of 3 seconds each to ensure maximum 
signal without saturation.  
Spectral calibration and processing were performed according to Robichaux-Viehoever et 
al. [31]. In brief, calibration for system response was calculated using a neon-argon lamp, 
naphthalene, and acetaminophen to correct for system wavenumber, laser excitation, and light 
throughput variations. Noise removal was accomplished by vertical binning of the 7 collection 
fibers (averaging along the intensity axis); horizontal binning to match the Nyquist limit of 
system spectral resolution; and finally smoothing via second-order Savitsky-Golay FIR filter. 
Fluorescence subtraction was accomplished using a modified polynomial fit method in which a 
fifth-order polynomial was fit to the fluorescence baseline. Subsequent to preprocessing 
algorithms, spectra were then normalized to mean spectral intensity to account for overall 
intensity fluctuations. Normalized spectra were analyzed as a function of time and spatial location 
with regards to the intensity of the most prominent peaks and the relative intensity of their ratios.  
To eliminate the influence of anatomical variations in skin, eleven Raman spectra (see 
Figure 1) were acquired from consistent sites on wounded and adjacent intact skin prior to 
preconditioning, after surgery, and daily thereafter until mice were culled for histology at days 4, 
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7, and 10. For peak ratio analyses, samples from intact skin immediately adjacent from the wound 
were separated from medial wound samples and lateral wound samples. At each of these time 
points, digital photography was used to document the wounds for future reference. 
2.4 Histology: 
After euthanasia, the entire dorsum of the mouse was excised and divided into      5 mm 
wide cross-sections of the wound and adjacent intact skin. Following 24 hour formalin fixation, 
histological cross-sections of the wounds were stained with Hematoxylin and Eosin (H&E) to 
visualize cellular organization and collagen deposition. Slides were analyzed using a microscope 
with a polarizing filter. Under polarized light, newer immature collagen displays less 
birefringence than its mature organized counterpart.  As a qualitative confirmation of Raman 
spectral analysis, photographs of the histology slides under standard and polarized light were 
visually examined for inflammatory cell concentration, epidermal thickness, collagen intensity, 
and collagen orientation  
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3. Results: 
3.1 Establishing normal tissue spectral behavior: 
Figure 2 illustrates a representative time course (increasing in vertical axis) of Raman 
spectra of untreated skin healing from the lateral spot (Figure 1, red) wound, starting prior to 
surgery, and ending on post-operative day 9 (POD9). The bold baseline indicates several peaks of 
interest in the intensity normalized Raman spectrum of untreated wild-type mouse skin prior to 
surgical incision. The greatest intensity differences seen throughout the wound healing time 
course (Figure 2 gray bars) also correspond to the most prominent pre-operative (Pre-Op) peak 
intensities: 1265 cm-1, 1304 cm-1, 1440 cm-1, and 1657 cm-1. The most notable changes in peak 
intensities relative to Pre-Op skin occurred between POD1 and POD3. The general shape of the 
spectrum seems to return to the baseline preoperative shape by POD 7 or 8. Examining individual 
peaks, most of the low wavenumber peaks including 723 cm-1, 964 cm-1, 1083 cm-1, and the 
doublet from 1265 to 1304 cm-1 undergo changes in relative intensity between POD1 and POD3 
that then return to Pre-Op intensity by POD7. Interestingly, several peak intensity changes that 
occur between POD1 and POD3 still remain, or even increase by POD7. Spectra indicate 
increased differences in the shoulder at 1118 cm-1 and peaks at 1440 cm-1, 1657 cm-1, and 1730 
cm-1. These results suggest that Raman spectra are sensitive to multiple distinct trends within the 
course of normal incisional wound healing. 
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Figure 2. A representative time course of Raman spectra from a single untreated wild-type 
(WT) lateral wound throughout the wound healing process indicates changes within two days 
of operation and gradual peak intensity recovery by POD7. Increasing time points (pre-
operative, POD 0-7) correlate to increasing y-axis value. Prominent peaks (gray bars) indicate 
changes throughout the time course at 1265 cm-1,  
1304 cm-1, 1440 cm-1, and 1657 cm-1. 
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Figure 3 provides statistical support for the trends represented in Figure 2. Top panels show mean 
spectra from untreated wounds in WT mice at POD2 and POD7 relative to Pre-Op spectra. 
Bottom panels indicate the probability of significant difference between the mean spectra using a 
paired Student's t-test for each wavenumber. Significance of the t-test is plotted as the probability 
of rejecting the null hypothesis (mathematically expressed as '1-p', where p is the probability of 
accepting the null hypothesis), such that significance increases as the value of '1-p' approaches 1. 
This test evaluates the null hypothesis that the intensity of a given wavenumber of Raman shift 
for a particular post operative day is the same as that of its matching pre-operative spectrum.  
Peak intensities at 964 cm-1, 1265 cm-1, and 1304 cm-1 exhibit statistically significant differences 
from Pre-Op spectra on POD2; however, on POD7 these peaks no longer show a statistically 
significant difference from Pre-Op spectra. This indicates a "recovery" of Pre-Op spectral 
intensity for these peaks. On the contrary, peak intensities at 1118 cm-1, 1440 cm-1, 1657 cm-1, 
and 1748 cm-1 do not exhibit statistically significant differences from Pre-Op spectra on POD2; 
however, on POD7 these peaks indicate a statistically significant difference from Pre-Op spectra. 
These findings indicate the development of separate spectral changes beyond POD7. 
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Figure 3. Paired t-tests illustrate recovery or persistence of peak intensity differences of 
mean spectra on POD2 and POD7 relative to the mean Pre-Op spectrum. Low 
wavenumber peaks including 726 cm-1,  960 cm-1,  1083 cm-1, 1122 cm-1,  and the doublet 
between 1265 and 1304 cm-1 illustrate peak intensity change at POD2 followed by 
recovery of pre-operative peak intensity by POD7. Peak intensity differences seen in 1440 
cm-1, 1657 cm-1, and 1730 cm-1 POD2 persist and even increase by POD7. 
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3.2 Spectral content of preconditioned wounds and effects of HSP70: 
Within the time course of untreated wild-type wounds, the period between POD1 and 
POD3 represents the greatest spectral departure from Pre-Op normal tissue. To examine how 
these downstream changes are affected  by HSP70 genetic expression and laser preconditioning, 
average spectra from the wound and adjacent skin were constructed for POD2, and two-sample t-
tests were conducted to explore the extent and location of spectral changes. Similar in layout to 
Figure 3, Figure 4 illustrates the downstream effects of HSP70 within treatment groups, in which 
a point-wise two sample t-test indicates the probability of rejecting the null hypothesis as a 
function of Raman shift. This test evaluates the null hypothesis that the intensity of a given 
wavenumber of Raman shift within a wild-type mouse wound is the same as that of an HSP70 
knockout wound. HSP70 knockout mice exhibit a significantly stronger spectral intensity through 
several lower wavenumber bands, including peak intensities at 723 cm-1, 782 cm-1, 898 cm-1, and 
964 cm-1. Spectra from HSP70 knockout mice also indicate significantly stronger peak shoulders 
at 1118 cm-1 and around 1657 cm-1. In contrast, wild-type mice exhibit significantly stronger peak 
intensities at 1083 cm-1, 1265 cm-1, 1304 cm-1, 1440 cm-1, 1657 cm-1, and 1730 cm-1.  For both the 
treated and untreated groups, there is a highly significant difference (p<0.001) between the 
Raman spectrum on POD2 of a wild-type and HSP70 knockout mouse for all prominent peaks. 
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Figure 4. Comparison of average wild-type and HSP70 knockout mouse wound Raman 
spectra on  POD2 indicates significant differences in normalized intensity at peaks of 
biological interest. Similar spectra results are found for preconditioned wounds on left as those 
seen for untreated wounds on right, indicating native difference in wound healing due to 
HSP70 activity. 
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Figure 5 illustrates the relative effect of the preconditioning upon mean POD2 Raman 
spectra within genetic mouse type. Laser preconditioning creates numerous differences in the 
Raman spectra of wild-type mouse wounds, but not in those of the HSP70 knockout mice. In 
wild-type wounds, significant differences were seen between the intensity of untreated and 
preconditioned peaks at 723 cm-1 and 1083 cm-1.  Comparing preconditioned wounds to their 
untreated counterparts, marginally significant differences (significant at α =.10) in the peaks of 
wounds in wild-type mice were seen at 1118 cm-1, 1265 cm-1, 1304 cm-1, 1440 cm-1, and 1657 cm-
1. Statistical significance was also observed as a function of laser preconditioning in wild-type 
mice through the shoulders of peaks including the valley between 1265 cm-1 and 1304 cm-1 (at 
1285 cm-1),  1440 cm-1 (between 1465 and 1475 cm-1), and 1657 cm-1 (at 1650 cm-1, 1703 cm-1, 
and 1730 cm-1). Within HSP70 knockout mice, statistical significant differences in spectra are 
observed only in the shoulders of peaks at 1083 cm-1 (at 1052 cm-1) and 1440 cm-1 (at 1489 cm-1). 
Ultimately, preconditioning induced marginally significant differences in the intensity of 
prominent Raman peaks of the normal wound healing time course (see Figure 2), but only in 
wild-type wounds.  
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Figure 5. Comparison of average preconditioned and untreated wound Raman spectra on  day2 
indicates few significant differences in normalized intensity at peaks of biological  interest for 
wild type samples on left, and no significant differences at peak locations for HSP70 knockout 
sample on right, suggesting that preconditioning requires HSP70 seen in wild type wounds. 
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3.3 Peak ratios elucidate the combined effects of HSP70 and preconditioning: 
While the analyses shown in Figures 2-5 were limited to absolute peak intensity, peak 
ratios examine relative intensity differences, allowing for a further analysis of specific spectral 
changes. For these analyses, Raman spectra were grouped by sample location to prevent the 
confounding effects of natural anatomical variation in skin (see Figure 1). Figure 6 illustrates the 
ratio of the normalized peaks at 1440 cm-1 to 1657 cm-1 with error bars (2 standard deviations in 
each direction) as a function of time for lateral wound samples (Figure 1, red). Within the context 
of wound healing, this ratio likely suggests the degree and quality of protein deposition and 
organization. The trend in ratio peak intensity is similar for both wild-type and HSP70 knockout 
wounds, exhibiting a decrease until POD3 and a subsequent recovery and even increase by 
POD7. This agrees with the trends exhibited in Figures 2 and 3. In comparing wild-type versus 
HSP70 knockout models, statistically significant differences (two sample t-test; p<.01) can be 
seen up to and including POD7. This trend is exhibited in both laser preconditioned (upper right 
panel) and untreated (lower left panel) wounds. Examination of the time course for this peak ratio 
yields similar significant trends (not shown) for medial wound spectra (Figure 1, dotted blue) and 
neighboring intact tissue (Figure 1, black).  
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Figure 6. Paired comparisons of time course (POD) of average peak ratio intensity of 
1440:1657cm-1 in lateral wound samples indicates significant differences between wounds 
in wild-type and HSP70 knockout mice for the first 6 days. No significant differences are 
seen in either wild type or HSP70 knockout as a function of preconditioning. Error bars 
represent 2 standard deviations (separation indicates p<0.05). Trends suggest that HSP70 
expression correlates to persistent downstream differences in wound healing. 
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Figure 7 shows the normalized peak ratio of 1304 cm-1 to 1265 cm-1 over time, indicating a 
significant difference (two sample t-test; p<.05) between the early wound healing processes in 
wild-type mice and those lacking HSP70. This ratio suggests a measure of either cellularity or 
cellular activity. The trend for both wild-type wounds and HSP70 knockout wounds indicates an 
initial increase in the ratio peak intensity at POD0, followed by a return to Pre-Op value (POD= -
1) by POD 3 or 4, and a subsequent ratio decay beyond POD4. In untreated wounds this 
difference is statistically significant (p<0.05) from Pre-Op until POD1; however, laser 
preconditioning of wild-type mouse wounds amplified this difference on both POD1 and POD2 
(compare lower left to upper right panel). Moreover, laser preconditioned wounds exhibit a 
significant difference in peak ratio between wild-type and HSP70 knockout mouse wounds from 
Pre-Op spectra up to and including POD5 (top right panel). This suggests that laser 
preconditioning extends the downstream biochemical effects of HSP70 expression for up to 3 
days. Ultimately, this preliminary analysis of peak ratios delineates the time course of specific 
differences seen as a function of HSP70 genetic expression as well as laser preconditioning. 
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Figure 7. Paired comparisons of time course (POD) of average peak ratio intensity of 
1304:1265cm-1 in lateral wound samples indicates significant differences between wild type and 
HSP70 knockout mice prior to and following surgery. Preconditioning prolongs significant 
differences between wild type and HSP70 knockout beyond POD1. Error bars represent 2 
standard deviations (separation indicates p<0.05). Trends suggest preconditioning prolongs the 
increase in ratio caused by HSP70, consistent with reported upregulation. 
 57
 
3.4 Histology confirms collagen organization: 
Standard microscopic analysis of H&E stained wound cross-sections established the 
wound healing time course. Separate readings from two expert pathologists agreed that the most 
prominent healing features occurred prior to POD4; that the wounds were largely reepithelialized 
by POD7; and most wounds were remodeling on POD10. Slides exhibited no difference in 
adjacent normal epidermal thickness between wounds in wild-type and HSP70 knockout mice. 
POD4 histological slides indicated that acute cellular infiltrates from initial inflammation were 
largely gone, and the wound environment was dominated by macrophages. Histological samples 
from POD7 indicated complete wound reepithelialization with little residual fibroplasia. 
Qualitative histological analysis using polarization microscopy on POD4 and POD7 was 
utilized to confirm results from Raman spectroscopy. To prevent bias from natural variation 
between animals, analysis was conducted comparing preconditioned and untreated samples from 
the same mouse. Figure 8 illustrates the trends seen on POD4. Healing wounds in wild-type mice 
show less collagen in the wound bed than HSP70 knockout counterparts; however, the 
organizational patterns of collagen are distinctly more heterogeneous in wounds of wild-type 
mice compared to HSP70 knockout mice. Both wild-type and HSP70 knockout preconditioned 
wounds show slightly more total collagen within the wound bed than their untreated counterparts. 
Figure 9 indicates the downstream results of HSP70 genetic expression and laser preconditioning 
treatment by examining differences on POD7. Preconditioned wounds of both wild-type and 
HSP70 knockout mice indicate more heterogeneity of collagen adjoining the repairing wound 
bed, relative to untreated counterparts. Untreated wounds demonstrate bright collagen 
birefringence; however, the fibers contributing to this birefringence intensity exhibit a strongly 
unidirectional distribution. Photographs in figures 8 and 9 are paired representative images that 
illustrate cumulative trends in qualitative analysis. 
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Figure 8. Polarized microscopy of H&E stained wound cross-sections at POD4 indicate 
increased quantity and directionality of striated collagen in samples from HSP70 knockout 
mice (right) regardless of pretreatment. Samples from WT mice show relatively less 
deposited collagen in the wound bed with a more heterogeneous directionality. 
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Figure 9. Polarized microscopy of H&E stained wound cross-sections at POD7 indicate 
directional striated collagen in samples from HSP70 knockout mice (right) and untreated wild 
type mice (lower left). Preconditioned samples (above) show more heterogeneous directionality 
than their untreated counterparts (below). Trends suggest that continued heterogeneous matrix 
replacement is prolonged by preconditioning, consistent with reported increased tensile strength. 
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4. Discussion: 
The use of probe-based Raman spectroscopy (RS) represents a novel method of real-time, 
in vivo, quantitative analysis of wound healing. In what we believe to be the first report of the 
impact of differential genetic expression on wound healing using Raman Spectroscopy,  this 
method was sufficiently sensitive to resolve the downstream tissue-level impact of HSP70 upon 
incisional wound healing. Moreover, the analysis of relative peak intensities in the Raman spectra 
delineated the time course effects of differential wound healing treatment response through non-
invasive, in vivo measurements. In our studies, RS represents a plausible method for future 
optimization and tracking of laser preconditioning towards clinical applications. The success of 
RS in this study also implies many applications in the investigation of future wound healing 
therapies. As a non-invasive technique to quantitatively probe tissue biochemistry, Raman 
Spectroscopy is especially promising for the evaluation of nascent wound healing therapies due to 
its applicability to both laboratory and clinical studies. Finally, the detection of differences in the 
wound healing time course of HSP70 knockout mice supports the future investigation of RS as a 
method for the differential diagnosis of altered or chronic wound healing. This avenue of 
investigation will also be furthered by recent advances in the automated classification of Raman 
spectra for cancer diagnosis [20]. 
 
 
 
4.1 Characterizing normal incisional wound healing 
In order to characterize tissue biochemistry modulation during wound healing with 
therapeutic intervention, changes were evaluated relative to the normal state of local tissue. The 
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time course of wild-type incisional wound healing seen in Figure 2 exhibits distinct trends within 
the first week of healing. Prominent peaks at both 1265 cm-1 and 1304 cm-1 change intensity 
relative to pre-operative spectra, yet recover normal intensity by POD7; however, the later 
changes seen in the peak intensities at 1440 cm-1 and 1657 cm-1 are amplified beyond POD7. 
Taken together with support from Figure 3 paired t-tests, trends in the significant differences may 
imply a spectral profile for known wound healing phases. In murine wound healing, the changes 
seen between POD1 and POD3 would likely correspond to the inflammatory phase of wound 
healing, supported by the histological observation of the absence of acute inflammatory cells by 
POD4. Moreover, the spectral results seen at and beyond POD7 would correlate to early 
remodeling phase of murine wound healing, supported by the histological observation of 
complete reepithelialization by POD7. While the correlation of spectral changes to the observed 
histological time course shows promise for the use of RS, a more detailed analysis is necessary 
before a spectral profile of specific wound healing phases can be established within the continuity 
of the wound healing process.   
Using tissue Raman literature, preliminary peak assignments have been made for the 
prominent peaks shown in Figure 2 to further illustrate the relevance of Raman spectral 
components in light of known wound healing parameters. Both 1265 cm-1 and 1304 cm-1 are 
associated specifically with the amide III (C-N stretch, N-H in-plane bend) bond of a protein in α-
helix configuration; however, while the former is more often correlated to structural proteins, the 
latter falls on the edge of the range associated with nucleic acids and histones, proteins involved 
in the packaging of DNA [12]. The peak at 1304 cm-1 has also been associated with the CH2 
twisting of lipids [32, 33], specifically the phospholipid membrane [23]. Regardless, both of these 
assignments correlate with cellularity and cellular activity. A Raman shift of 1440 cm-1 is 
associated with the CH2 stretch of protein side chains, and is most often associated with the 
quantity of structural proteins in tissue [12]. While the peak intensity of the CH2 stretch at 1440 
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cm-1 likely has some contribution from the bonds found in lipids, the large degree of temporal 
change seen in this peak supports the assignment to protein side chains in the context of wound 
healing.  The peak at 1657 cm-1 relates to the Amide I bond, and subsequently to the 
conformation and secondary structure of proteins. As an aside, mouse skin exhibits a notable lack 
of the distinct phenylalanine peak (1006 cm-1) seen in human skin samples. 
 
4.2 Spectral content implies HSP70 role in wound healing and laser preconditioning: 
Given the suggested significance of the strongest spectral components in murine skin, 
further analysis of the effects of laser preconditioning required an understanding of how these 
spectral components vary in the course of wound healing, especially as a function of the presence 
or absence of HSP70. Figure 4 suggests that HSP70 plays an active role in the early stages of the 
wound healing process, although the results do not identify the precise mechanism. Note that the 
differences in peak intensity throughout the spectrum are seen regardless of laser preconditioning. 
Furthermore, the involvement of all prominent spectral peak intensities suggests the involvement 
of HSP70 in both cellular and acellular components crucial to normal repair. The wide variety of 
biochemical changes illustrated by peak intensity differences is supported by the ubiquity of 
HSP70, as well as its numerous roles in protein folding, re-folding, and apoptotic pathway 
suppression [34, 35]. 
Beyond the involvement of HSP70 in normal wound healing, Raman spectroscopy 
suggests that the presence of HSP70 is directly involved with the downstream effects of laser 
preconditioning. Differences seen in the peak intensities of wounds in wild-type but not HSP70 
knockout mice as a function of preconditioning (Figure 5) supports the hypothesis that HSP70 
upregulation is necessary to affect the known treatment response to laser preconditioning. While 
the correlation of HSP70 upregulation to downstream preconditioning effects had been well 
established [8, 9, 36, 37], the differential effects of the presence of HSP70 expression on the laser 
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preconditioning therapy have not been quantified otherwise. Only marginal statistical significance 
(significant at α =.10) was seen in prominent peaks as a function of laser preconditioning. It is 
possible that this study was not sufficiently powered to detect significance in the small changes of 
absolute peak intensity. Furthermore, this analysis averaged spatially independent samples, 
including the confounding factors of skin biochemical and anatomic variation. Finally, results 
found by Wilmink et al. were examined at later time points, suggesting that analysis at any single 
time point early in the wound healing process might not be sufficient to capture any accumulated 
developments.  
 
4.3 Mouse model and experimental limitations: 
The extent and degree of experimental analysis was limited largely by the use of a mouse 
model. The model represents the only available HSP70 knockout, chosen for the ability to 
exercise a controlled examination of the role of HSP70 in normal and laser preconditioned wound 
healing. Unfortunately, it was not possible to analyze the combined effects of HSP70 and 
preconditioning using Raman spectra during the remodeling phase of wound healing (>7 days). 
Currently, the mouse model of HSP70 knockout mice is only available on the C57BL/6 
background, which is known to develop abnormal skin pigment after around 10 days in response 
to even mild abrasion. 
A brief pilot study (data not shown) indicated that this pigmentation was not the result of 
either laser preconditioning or depilation. Simple trimming of dorsal hair was sufficient to cause 
hyper-pigmentation during hair regrowth under normal mouse model activity. The development 
of this severe hyper-pigmentation significantly changes tissue optical properties and leads to 
peaks in the Raman fingerprint region that obfuscate analysis. Despite efforts to recover Raman 
spectra, the development of pigment (observed beyond POD8) makes Raman analysis of the 
remodeling phase of wound healing intractable with this animal model. The presence of pigment, 
 64
coupled with low sample numbers beyond POD7, is responsible for the large error bars seen in 
Figures 6 and 7, as well as the gross changes in spectral shape in Figure 2 on POD8 and POD9. 
The data was included to demonstrate this limitation of the model for future reference and also 
because some mice did not develop pigmentation and the beginnings of remodeling trends offer a 
more comprehensive shape to the peak ratios relative to expected wound healing time course. 
These model limitations further prevent the spectral confirmation of long-term preconditioning 
effects reported by Wilmink et al. [8]; however, the model was sufficient to confirm the active 
role of HSP70 and provide some insight into biochemical response to laser preconditioning due to 
HSP70 upregulation. 
 
4.4 Significance of peak ratios through the wound healing time course: 
Eliminating confounding factors seen in the comparison of absolute wavenumber 
intensity, peak ratios isolated to particular anatomical locations allowed for further analysis of 
specific changes over time. The ratio of peaks at 1440 cm-1 to 1657 cm-1 compares the CH2 
stretch of proteins, found in protein side chains, to the presence of the Amide I bond, found near 
amino acid residue linkages. As a ratio, these wavenumbers yield information regarding the 
degree of conformation and organization of proteins relative to their quantity. Within the context 
of wound healing, this ratio likely suggests the degree and quality of protein deposition and 
organization. Recall the functions of HSP70 as a chaperone during protein folding and repair 
[35]. Results by Wilmink et al. indicate decreased scarring and increased maximum tensile load 
of wounded skin samples as a function of HSP70 upregulation on POD7 and POD10, implying 
increased deposition and organization of structural proteins due to HSP70 activity [8]. Consistent 
with these results, the significant difference of ratio peak intensity between wild-type and HSP70 
knockout mice throughout the first week of healing supports the hypothesis that HSP70 is 
actively involved in the deposition and repair of structural proteins in the extracellular matrix. 
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Finally, the observations of similar significant trends from other wound spatial locations and 
adjacent intact skin implies the collection of wound spectral characteristics from the edge of the 
wound bed, mitigating possible future confounding factors in more complex wound 
environments. 
The ratio of peaks at 1304 cm-1 to 1265 cm-1 compares specific amide III bonds of 
proteins in α-helix configuration. The 1265 cm-1 intensity is more often correlated to structural 
proteins, while the 1304 cm-1 is associated with both histones and nucleic acids, and subsequently 
net nuclear material [12]. By differentiating between neighboring peaks both associated with the 
amide III bond, the ratio suggests a measure of either cellularity or cellular activity. Note that the 
alternative assignment of 1304 cm-1 to the CH2 twisting [32, 33] in phospholipid membranes [23], 
yields a ratio with similar implications on cellularity or cellular activity. Because the 1265 cm-1 
intensity alone does not discriminate between extracellular or intracellular protein, further studies 
would be needed to narrow these observations towards either cellularity or cellular activity.  
Significant differences were observed in ratio peak intensity between wounds in wild-
type and HSP70 knockout mice prior to POD2, regardless of laser preconditioning. This implies 
that HSP70 activity has a direct effect on cellularity during the early phases of wound healing, 
possibly through its known suppression of apoptotic signaling pathways. Moreover, laser 
preconditioning protocol led to an increase of this elevated cellular trend by at least two days. It is 
important to note the time range of these results. Increased cellularity occurring within the wound 
closure and inflammation phases as seen in Figure 8 may lead to a decrease in total healing time 
and increased tissue organization. Recall that histological observations indicated a lack of acute 
inflammatory infiltrates and the presence of reepithelialization on POD4. This trend fades 
appropriately as the reepithelialization phase of wound healing makes way for the remodeling 
phases, during which any increased cellularity would be seen as a negative impact, prolonging the 
wound healing process. 
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4.5 Histology confirms RS trends for HSP70 and laser preconditioning 
While qualitative histological analysis establishes some boundaries for wound healing 
phases relative to observed spectral differences, the result implies limited applicability of semi-
quantitative analysis of healing features at these precise timepoints. The incisional wound model 
and histological timepoints were chosen to mimic the experimental protocol of Wilmink et al. 
while providing optimal environment for Raman measurements; however, incisional wounds 
provide little volume for quantitative histology. Nevertheless, the lack of acute cellular infiltrates 
on POD4, as shown in Figure 8, supports peak ratio results for cellularity (1304 cm-1 to 1265 cm-
1) in which the greatest difference as function of preconditioning was seen on POD2. 
Polarization microscopy was used to confirm the relative protein conformation and 
organization seen in the peak ratio of 1440 cm-1 to 1657 cm-1. Collagen birefringence intensity 
correlates to maturity, and the directionality of birefringent fibers is indicative of organizational 
heterogeneity and indirectly, the degree of crosslinking. This can be seen macroscopically in scar 
tissue as large scale striation patterns. Results from Wilmink et al. [8] indicate that optimization 
of preconditioning based on maximal HSP70 upregulation indicated increased tensile strength 
and cosmetic appearance, both indicative of structural protein content and organization. 
The lower quantity and greater heterogeneity of wild-type wound bed collagen suggested 
by Figure 8 may indicate that the intra-cellular protein-folding role of HSP70 indirectly 
influences the subsequent organization of collagen incorporation into the extracellular matrix. 
This would both confirm results by Wilmink et al. as well as support Raman spectra results from 
the 1440 cm-1 to 1657 cm-1 peak ratio (Figure 8). The relative increase in collagen heterogeneity 
seen in both wild-type and preconditioned wounds on POD7  (Figure 9),  when examined in 
reference to POD4 observations, indicates that preconditioning may have some effect on other 
active wound healing proteins independent of HSP70. However, the heterogeneity is more 
pronounced in wild-type wounds, consistent with the chaperone protein activity associated with 
HSP70 as well as the results seen from the peak ratio of 1440 cm-1 to 1657 cm-1. 
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Untreated wounds demonstrate bright collagen birefringence on POD7, indicative of 
collagen maturity; however, the strongly unidirectional distribution of the collagen indicates less 
organization and the potential for greater scarring. While quantitative analysis of both 
directionality and intensity were possible, it is important to note that hair follicle regrowth could 
have drastically skewed results. The presence of hair follicles, while indicative of high quality 
healing, also manifests as striations in collagen when the histological section is shallow of the 
follicular cross section. Therefore semi-quantitative analyses would either have included 
automated error or human bias. Reported trends were the result of careful analysis of serial 
histological samples to exclude the influence of hair follicles on collagen organization. 
Subsequently photographs in figures 8 and 9 are paired representative images that illustrate 
cumulative trends in qualitative analysis. 
 
4. Conclusions and Future Directions: 
Raman spectral analysis is consistent with the hypothesis that HSP70 plays an active 
intracellular role in subsequent collagen deposition and matrix organization during the early 
stages of wound healing. This finding is consistent with the HSP family role as chaperone 
proteins responsible for the refolding and repair of damaged protein. It is important to recall that 
HSP70 is believed to be an intracellular protein, yet its expression will have an indirect effect on 
the extracellular matrix proteins that are produced within cells in the wound bed. Moreover, 
Raman spectra delineated significant differences in gross biochemical content between wounds in 
wild-type and HSP70 knockout mice. Preconditioning had its greatest effects on biochemical 
content in early stages of wound healing. Moreover, differences seen in the spectral intensity 
distribution of wounds in WT mice were more significant than those in HSP70 knockout mice, 
suggesting that preconditioning amplifies natural HSP70 effects via upregulation.  
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Peak ratio analysis indicated that HSP70 function during wound healing significantly 
affects protein conformation and organization prior to remodeling. Moreover, HSP70 was found 
to be responsible for increased cellularity in the first few days of wound healing, and 
preconditioning extended this effect, accelerating the natural phases of wound healing. 
Polarization microscopy confirmed the impact of HSP70 and preconditioning on the downstream 
organization of collagen in wound extracellular matrix.  
Despite study limitations due to animal model physiology and availability, Raman 
spectroscopy proved an invaluable modality for the assignment of pseudo biomarkers for a 
detailed analysis of the role of HSP70 in wound healing and its relationship with preconditioning 
therapy. Its non-invasive nature allowed for the collection of a complete spatio-temporal 
distribution of biochemical content throughout the wound healing process; subsequently yielding 
statistically significant results of a multivariate data set with only 38 wounds. To the best of our 
knowledge, this paper represents the first in vivo Raman spectroscopy analysis of the wound 
healing time course as a function of model genetic expression and treatment. It is important to 
note that none of the instrumentation, processing algorithms, or peak assignments have been 
thoroughly optimized for wound healing biology. Thus the full potential of Raman spectroscopy 
has yet to be realized for either the analysis of wound healing therapeutic efficacy or differential 
diagnosis. Current efforts include closed-loop automated spectral processing and classification 
algorithms for wound healing diagnosis. Nevertheless, the spectral dataset confirms that the laser 
preconditioning protocol effects are a direct result of HSP70 upregulation. Furthermore, Raman 
spectroscopy will be an analytical tool capable of assessing optimization of future conditioning 
protocols during translation of laser thermal modulation to clinically relevant skin models and 
chronic wound scenarios. 
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CHAPTER III 
 
FUTURE DIRECTIONS 
 
 For the first time, Raman spectra have been characterized as a function of both space and 
time for a healing incisional wound in vivo. The role of HSP70 was examined in both normal and 
laser preconditioned wound healing. Results from this study suggest that HSP70 plays an active 
role in normal wound healing. Moreover, the downstream tissue-level effects of HSP70 are 
augmented by laser preconditioning. Raman spectra identified differences in wound healing time 
course as a function of genetic expression and treatment response. Raman spectra peak rations 
suggest that HSP70 increased protein conformational organization throughout the first 
postoperative week. Peak ratios also indicate HSP70 induced cellularity increases during 
inflammatory and early reepithelialization phases. Finally, the same peak ratios suggest that laser 
pretreatment extends the duration of HSP70 dependent increased cellularity. While the results 
justify continuing translation from a preconditioning to conditioning environment to augment 
healing of existing wounds as a function of HSP70 expression, they also suggest numerous 
avenues for the application of Raman Spectroscopy as a non-invasive, hand-held, quantitative, 
real-time, high-throughput, relatively inexpensive method of wound healing diagnosis. 
 Laser preconditioning has been established in animal models, mostly in mice, and its 
mechanisms are beginning to become clear. Preconditioning and its post-wound "conditioning" 
counterpart now require transition to more physiologically relevant animal models (rats then 
pigs) to secure future clinical relevance. Clinically, preconditioning is practically limited to 
elective surgeries and possible planned grafting applications, though the latter has not been 
established. However, conditioning (applying laser light after the wound has already been 
induced) would be most useful in impaired wound healing. Application of laser conditioning to 
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impaired wounds will require optimization and therefore some method of non-invasive in-situ 
feedback. Therefore both laser treatment and Raman spectroscopy will focus on wound models 
representing the highest clinical need. Development of Raman spectroscopy for classification and 
content quantification via convolution will be evaluated in diabetic and aged wound models of 
splinted excisions and ischemic flaps. The key to success in this study will be establishing a 
spectral characteristic of each of the phases of wound healing and how they change as a function 
of disease.  
 Raman spectroscopy was established in the most basic wound model, limiting 
interference due to changing light transport dynamics that will be seen in a large or impaired 
wound bed. Feasibility studies will be conducted to ensure sample size needs for future statistical 
power measures by quantifying machine variance and sample variance in normal rat excisional 
wounds. This data will also be used to ensure the validity and stability of fluorescence subtraction 
algorithms developed for cancer detection. These studies will require brief acquisition parameter 
optimization. Surgical materials will be analyzed for possible scaled background subtraction to 
prevent interference. This work is already under way and its results will allow for rapid transition 
to the rat wound model with laser conditioning when needed. 
To ensure feasibility of transition of preconditioning to conditioning, an initial parametric 
optimization study will utilize incisional wounds in our HSP70–luciferase mouse model. The 
study will test two optimized protocols (constant temperature and constant irradiance) while 
evaluating several time points to determine to what extent post wound generation is the therapy 
protocol valid. In all mouse studies, HSP70 upregulation will be measured through 
Bioluminescence Imaging at several time points prior to and post treatment. Downstream effects 
will be evaluated with HSP70 immunohistochemistry and tensiometry at time points similar to 
those used for previous studies. Development of a protocol for excisional wounds will require 
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beam shaping or blocking as well as laser output scaling to achieve the same irradiances as in the 
parametric study. Excisional wounds will be evaluated using HSP70 immunohistochemistry and 
advanced histological scoring, made possible in this model due to large scale reepithelialization. 
With optimized data from murine excisions, a short parametric optimization will allow for 
transition to rat excision wounds. Without luciferase transgene, rat studies will depend on 
downstream effects of HSP70 measured by Raman spectroscopy and histology to confirm 
treatment efficacy. Results of these studies will be a starting point for ischemic flap and diabetic 
excision treatment in rats that will utilize Raman spectroscopy. Feasibility studies will provide 
optimization for real-time in vivo analysis for these studies. 
Established treatments for healing wounds are mostly protocols to improve on older 
dressings, offloading, or debridement techniques. These types of advances are needed but focus 
on decreasing healing time by avoiding complications that retard wound healing, rather than 
actually accelerating the healing process. There are a limited number of successful topical gels 
containing growth factors though they remain largely experimental and very expensive. Contact- 
based heating methods that currently exist for other applications require clinically intractable, 
unacceptable risk or infection, pain and tissue damage that prevent use in this field. Wounds also 
tend to occur over bony processes, making controlled contact and precise conduction difficult. 
Laser thermal modulation treatments directly address these limitations by tuning wavelength and 
irradiance to achieve non-contact, controlled heating in time and space. In contrast to topical 
therapies, laser conditioning is relatively inexpensive and utilizes the body's endogenous 
response. This therapy has a potential to improve healing time and tissue quality, leading to a 
decrease in complications and reoccurrences. 
Current wound healing diagnostics differ greatly between laboratory and clinical 
research, often cited as the source of great disparity in recent study results. Clinical methods are 
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comprised of photometric calculations of closure, subjective scoring rubrics, or invasive biopsies. 
Laboratory methods are more quantitative but destructive or very limited in scope. Tensiometry, 
a common laboratory method, provides biomechanical information about the healing wound at 
the expense of destroying the sample. Histology provides excellent information about structure 
and content, but requires sample removal, preparation and scoring by a team of experts. Raman 
spectroscopy directly addresses these limitations as a complementary modality for in-situ, non-
invasive, quantitative measures of tissue-level properties. While Raman will not provide the 
precision of immunohistochemistry, it has the advantages of near-realtime collection and 
automated processing in a hand-held system. Raman spectroscopy has the potential to improve 
differential diagnosis in the clinic while providing a modality for testing new therapies that 
readily translates from the laboratory to the clinic. 
 
